
Engineered endolysin proteins neutralizing antibiotic-resistant meningitis bacteria in the brain.
Image Credit: Scientific Frontline / stock image, AI generated
Scientific Frontline: Extended "At a Glance" Summary: Engineered Dual-Action Antibacterial Proteins
The Core Concept: Researchers have engineered a chimeric antibacterial protein that simultaneously eliminates antibiotic-resistant bacteria and neutralizes the destructive toxins they release.
Key Distinction/Mechanism: Unlike traditional antibiotics that often struggle to cross the blood-brain barrier, this engineered protein utilizes a bacteriophage-derived endolysin (Cpl-1) to destroy the bacteria while an attached peptide binds and neutralizes pneumolysin, the major toxin responsible for inflammation and neuronal damage in Streptococcus pneumoniae infections.
Major Frameworks/Components:
- Chimeric protein engineering for dual-action pathogen lysis and toxin neutralization.
- Utilization of bacteriophage endolysins to bypass traditional antibiotic resistance mechanisms.
- Targeted reduction of neuroinflammation and neuronal injury in the central nervous system.
- Blood-brain barrier permeability in neuropharmacological drug design.
.png)

















